Approved by the U.S. FDA in September 2010, fingolimod (also referred to as FTY720) is the first approved oral therapy for the relapsing-remitting form ofmultiple sclerosis (RRMS).
基本文件流程错误SQL调试用户
请求信息 : 2025-04-02 13:40:43 HTTP/1.1 GET : https://senovatech.com/anti_bacteria/207.html